683 Capital Management, LLC Wave Life Sciences Ltd. Transaction History

683 Capital Management, LLC

$1.28 Billion
Q2 2025

A detailed history of 683 Capital Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, 683 Capital Management, LLC holds 4,100,000 shares of WVE stock, worth $29.6 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares

4,100,000

Previous 3,925,000 4.46%

Holding current value

$29.6 Million

Previous $31.7 Million 15.97%

% of portfolio

2.09%

Previous 2.55%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.48 - $8.1 $959,000 - $1.42 Million	175,000 Added 4.46%	4,100,000 $26.7 Million
Q1 2025 May 15, 2025	BUY	$8.08 - $13.51 $1.13 Million - $1.89 Million	140,000 Added 3.7%	3,925,000 $31.7 Million
Q4 2024 Feb 14, 2025	SELL	$8.0 - $16.44 $3.32 Million - $6.82 Million	-415,000 Reduced 9.88%	3,785,000 $46.8 Million
Q3 2024 Nov 14, 2024	SELL	$5.12 - $9.01 $5.76 Million - $10.1 Million	-1,125,000 Reduced 21.13%	4,200,000 $34.4 Million
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $109,500 - $162,000	-25,000 Reduced 0.47%	5,325,000 $26.6 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $885,000 - $1.71 Million	-250,000 Reduced 4.46%	5,350,000 $33 Million
Q4 2023 Feb 14, 2024	SELL	$4.16 - $6.87 $1.04 Million - $1.72 Million	-250,000 Reduced 4.27%	5,600,000 $28.3 Million
Q3 2023 Nov 14, 2023	SELL	$3.56 - $5.75 $644,360 - $1.04 Million	-181,000 Reduced 3.0%	5,850,000 $33.6 Million
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $108,810 - $145,390	31,000 Added 0.52%	6,031,000 $22 Million
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $5.16 Million - $11.4 Million	-1,622,348 Reduced 21.28%	6,000,000 $42 Million
Q3 2022 Nov 14, 2022	BUY	$2.37 - $4.28 $239,607 - $432,708	101,100 Added 1.34%	7,622,348 $27.5 Million
Q2 2022 Aug 15, 2022	BUY	$1.23 - $3.25 $8.68 Million - $22.9 Million	7,059,201 Added 1527.81%	7,521,248 $24.4 Million
Q1 2022 May 16, 2022	BUY	$2.0 - $3.28 $549,838 - $901,734	274,919 Added 146.91%	462,047 $924,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $1.18 Million - $1.94 Million	-375,842 Reduced 66.76%	187,128 $588,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $307,923 - $448,346	62,970 Added 12.59%	562,970 $2.76 Million
Q2 2021 Aug 16, 2021	BUY	$5.65 - $7.47 $2.83 Million - $3.74 Million	500,000 New	500,000 $3.33 Million

Others Institutions Holding WVE

# of Institutions

188

Shares Held

133M

Call Options Held

495K

Put Options Held

36.2K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $626M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account

683 Capital Management, LLC Wave Life Sciences Ltd. Transaction History